Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Period Statement

14 Jul 2006 07:00

Gyrus Group PLC14 July 2006 14th July 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its interim results announcement on 12th September 2006. The Group's reported revenues for the six months to 30th June 2006 areanticipated to be approximately Β£107 million representing growth of over 125% onthe previous year (2005: Β£47.3 million). Proforma organic revenue growth (whichassumes a full period comparative for the ACMI business which was acquired on21st July 2005) is expected to be marginally over 10%. The legacy Gyrusbusinesses grew revenue by approximately 17% over the first half of 2005 (12% ona constant exchange rate basis). Good performances from the Group's proprietaryDivisions in the US and the Partnered Technologies Division were partly offsetby a weaker performance in international markets, where the integration ofinternational distributors during the period caused a shortfall in revenues. The Surgical Division's new PlasmaCision-derived products (G400 generator,Plasma Trissector, Plasma J Hook) were introduced to the general surgery marketin late March and the technology has been well received during this initialevaluation phase. At the end of the period there were approximately 100 G400generators either placed or sold into the surgical market and the divisionachieved revenue in excess of $1 million from the PlasmaCision portfolio. The Urology & Gynaecology Division had a slower first half when compared to astrong 2005 result pre-acquisition, however the adoption of PK SuperPulse intothe legacy ACMI urology accounts has started well with sales in excess of theCompany's forecasts. New product introductions, including the early evaluationof the new digital ureteroscope, show significant potential for the second halfof 2006. The integration programme has continued on track and savings from this, togetherwith revenue orientated towards more profitable US domestic disposables sales,is expected to result in a significant enhancement to operating profitability. Subject to any unforeseen adjustments it is anticipated that underlying "adjusted" earnings per share (excluding amortisation of acquired intangibleassets, integration costs and deferred tax adjustments) for the six months to30th June 2006 will be in line with consensus expectations, which currentlystand at 7.3 pence per share (H1 2005: 5.1 pence). Brian Steer, Executive Chairman of Gyrus said: "The first half of 2006 has been a successful period of change; we have madesignificant inroads into the integration programme and have started tore-orientate the legacy ACMI business towards our disposable devices businessmodel. At the same time we have successfully introduced our important newPlasmaCision technology. In addition, we look forward to a number of potentiallysignificant new product launches in the second half of 2006." Enquiries: Gyrus Group PLCBrian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial DynamicsBen Atwell 0207 269 7242 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Nov 200711:55 amRNSEPT Disclosure
20th Nov 200711:42 amRNSRule 8.3- (Gyrus Group PLC)
20th Nov 200711:42 amRNSRule 8.3- Gyrus Group PLC
20th Nov 200711:25 amBUSRule 8.3 - Gyrus Group Plc
20th Nov 200710:53 amRNSEPT Disclosure
19th Nov 20073:57 pmRNSHolding(s) in Company
19th Nov 20077:02 amRNSAcquisition by Olympus
16th Nov 20077:01 amRNSStatement re Patent Dispute
9th Nov 20075:47 pmRNSHolding(s) in Company
7th Nov 200712:51 pmRNSHolding(s) in Company
31st Oct 20072:07 pmRNSTotal Voting Rights
29th Oct 200711:00 amBUSGyrus ACMI Introduces the World's First Endoscope Protection System (EPS) Designed to Prevent Accidental Laser Damage
25th Oct 20074:24 pmBUSGyrus ACMI to Market Revolutionary ''Bagless'' OPTION-v(TM) Valved Urinary Catheters
4th Oct 20079:22 amRNSHolding(s) in Company
1st Oct 20075:56 pmRNSTotal Voting Rights
24th Sep 20075:03 pmRNSHolding(s) in Company
17th Sep 20072:13 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSInterim Results
3rd Sep 20078:33 amRNSTotal Voting Rights
17th Aug 20079:13 amRNSDirector/PDMR Shareholding
31st Jul 20075:45 pmRNSTotal Voting Rights
30th Jul 20074:58 pmRNSFurther re Additional Listing
27th Jul 20073:34 pmRNSAdditional Listing
17th Jul 20077:00 amRNSTrading Statement
8th Jun 20073:30 pmRNSDirector/PDMR Shareholding
8th Jun 20073:24 pmRNSDirector/PDMR Shareholding
8th Jun 20073:20 pmRNSBlocklisting Interim Review
6th Jun 20077:01 amRNSDirector/PDMR Shareholding
4th Jun 20075:21 pmRNSDirector/PDMR Shareholding
1st Jun 20077:01 amRNSAppointment of CEO
31st May 20072:11 pmRNSTotal Voting Rights
24th May 200710:12 amRNSHolding(s) in Company
11th May 20074:18 pmRNSDirector/PDMR Shareholding
2nd May 20072:41 pmRNSResult of AGM
2nd May 20072:33 pmRNSTotal Voting Rights
30th Apr 20074:49 pmRNSResult of AGM
23rd Apr 20073:14 pmRNSHolding(s) in Company
20th Apr 20074:07 pmRNSAnnual Information Update
5th Apr 20072:48 pmRNSAnnual Report and Accounts
30th Mar 20073:26 pmRNSTotal Voting Rights
27th Mar 20076:23 pmRNSDirector/PDMR Shareholding
27th Mar 20076:17 pmRNSDirector/PDMR Shareholding
27th Mar 20076:01 pmRNSHolding(s) in Company
26th Mar 200711:50 amRNSDirector/PDMR Shareholding
19th Mar 20072:37 pmRNSHolding(s) in Company
19th Mar 20072:30 pmRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
13th Mar 20074:03 pmRNSHolding(s) in Company
13th Mar 20073:56 pmRNSHolding(s) in Company
28th Feb 200712:33 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.